Pain Relief Investigation of NeuroModulation Therapy in Adult Humans
This study has been terminated.
Sponsor:
Fralex Therapeutics
Collaborator:
PharmaNet
Information provided by:
Fralex Therapeutics
ClinicalTrials.gov Identifier:
NCT00253032
First received: November 11, 2005
Last updated: March 2, 2006
Last verified: March 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.
| Condition | Intervention | Phase |
|---|---|---|
|
Chronic Musculoskeletal Pain |
Device: PRIMA |
Phase 3 |
| Study Type: | Interventional |
| Official Title: | PRIMA Study: Pain Relief Investigation of NeuroModulation Therapy in an Adult Population: A Double Blind, Randomized, Multicenter, Placebo Controlled Trial. |
Further study details as provided by Fralex Therapeutics:
Eligibility Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00253032 History of Changes |
| Other Study ID Numbers: | F05001 |
| Study First Received: | November 11, 2005 |
| Last Updated: | March 2, 2006 |
| Health Authority: | United States: Food and Drug Administration Canada: Health Canada |
ClinicalTrials.gov processed this record on May 16, 2013